Skip To Main Content
Eva Yin on Muck Rack

Eva Yin

As seen in: JD Supra, Computer & Internet Lawyer, Westlaw Today
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Eva

Contact Eva, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

FDA Announces Funding Opportunity for Research on Digital Health Technologies in Drug and Biologic Development

|
By Ty Kayam, Eva Yin
| JD Supra
Key Takeaways The U.S. Food and Drug Administration (FDA) is offering up to $2.2 million to fund research addressing key questions about the use of digital health technologies (DHTs) in drug and biologic development. Applications are due by August 20, 2026. The agency encourages applications for projects that focus on validation of digital measures, development of DHT-derived endpoints, evaluation of continuous data streams, and use of DHTs to identify early manifestations of chronic disease.
Open in Who Shared Issue with article?

FDA Announces Funding Opportunity for Research on Digital Health Technologies in Drug and Biologic Development

|
By Ty Kayam, Eva Yin
| wsgr.com
Key Takeaways The U.S. Food and Drug Administration (FDA) is offering up to $2.2 million to fund research addressing key questions about the use of digital health technologies (DHTs) in drug and biologic development. Applications are due by August 20, 2026. The agency encourages applications for projects that focus on validation of digital measures, development of DHT-derived endpoints, evaluation of continuous data streams, and use of DHTs to identify early manifestations of chronic disease.
Open in Who Shared Issue with article?

FDA’s Home as a Health Care Hub Initiative and the READI-Home Innovation Challenge: Key Takeaways for Device Sponsors

|
By Ty Kayam, Eva Yin
| JD Supra
Key Takeaways The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) opened its READI-Home Innovation Challenge, offering up to nine device sponsors early, focused engagement on home-use devices that may help reduce hospital readmissions; submissions are due by September 30, 2026, with participants selected by December 4, 2026.
Open in Who Shared View Duplicates (2) Issue with article?
See all 39 licensed articles (40 Total)